Clinical Trial Update: "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for JZP-110 evaluating safety and efficacy in excessive daytime sleepiness associated with narcolepsy completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• JZP-110

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23